Search Thermo Fisher Scientific
Population genotyping projects are enabling precision medicine decisions and research, leading to improved health care outcomes. Many national governments and large organizations are investing in scaling up genotyping infrastructure to support personalized solutions.
The Axiom Solution consists of a technology platform that includes assay biochemistry, automated and manual target preparation options, multiple array plate formats, and array processing on the GeneTitan Multi-Channel Instrument. This solution has applications in human genetics research and microbiome research.
The Axiom assay and workflow begins with purified genomic DNA. The first part of the assay and workflow is Target Preparation, which includes whole genome amplification on day one, followed by DNA fragmentation and overnight precipitation on day two. On day three the DNA is resuspended and prepared for hybridization on the array. Finally, washing, ligation, and staining occurs on the GeneTitan instrument followed by scanning of the plate. Target preparation aims to prepare the genomic targets of interest so that they can be successfully attached, or “hybridized” to the synthesized probes on the microarray for accurate results. Following hybridization, array processing involves washing non-specific binding DNA, scanning the microarray plate to detect the fluorescence signal from the genomic targets of interest. Finally, genotypes are reported in Axiom Analysis Suite.
Let’s dive deeper into each step:
The above steps (excluding data analysis) have been optimized into a shortened two-day workflow, the Axiom Propel Workflow, completing scanning of arrays by the end of day 2. In addition, the Axiom Propel Workflow has been optimized to include benchtop automation to increase the throughput through the workflow as well, processing more plates in two days than the standard manual Axiom 2.0 assay.
For Research Use Only. Not for use in diagnostic procedures.